The longer weight loss GLP-1 drugs like Ozempic and Wegovy have been on the market, the more side effects people are ...

The drug is now available for prescription in New Zealand but there are clouds to go along with the silver linings - such as potential vision loss.

June 6 (Reuters) - Novo Nordisk's (NOVOb.CO) popular weight-loss and diabetes drugs Wegovy and Ozempic may in very rare cases cause a serious eye condition that can lead to vision loss, the European ...

Recent research introduces a soft, injectable material designed for use in the eye to help protect and support damaged ...

Clearance of the New Drug Application for ART25.12 allows Artelo to begin a Phase I study for the drug in chemotherapy-induced peripheral neuropathy. The FDA has granted clearance to Artelo ...

Peripheral Neuropathy Treatment Market Landscape 2025-2029: Robust Drug Pipeline to Expand the Market by $481 Million Research and Markets Fri, Jun 6, 2025, 10:17 AM 3 min read ...

With that, the phase 1 clinical trial of this drug will advance to the next step, which will include more subjects and an evaluation of higher doses of the investigational drug. Artelo says that other ...

A phenomenon largely ignored since its discovery 100 years ago appears to be a crucial component of diabetic pain, according to new research from The University of Texas at Dallas’ Center for Advanced ...